efimosfermin

News

GSK decided to abandon a TIGIT-targeted drug for cancer this week, then hatched a plan to replace it with a candidate for liver disease MASH.

News

According to multiple press reports citing anonymous insider sources, Dr Martin Makary has resigned after a year at the head of the FDA.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.